Literature DB >> 17604779

NCI and the STELLAR trial.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17604779     DOI: 10.1016/S0140-6736(07)60987-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  1 in total

1.  Tamoxifen vs Raloxifene vs Exemestane for Chemoprevention.

Authors:  Laura Reimers; Katherine D Crew
Journal:  Curr Breast Cancer Rep       Date:  2012-09-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.